ondansetron has been researched along with ANS (Autonomic Nervous System) Diseases in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roczniak, W | 1 |
| Babuśka-Roczniak, M | 1 |
| Kwapuliński, J | 1 |
| Brodziak-Dopierała, B | 1 |
| Widuchowski, W | 1 |
| Cipora, E | 1 |
| Nowak, P | 1 |
| Oświęcimska, JM | 1 |
1 other study available for ondansetron and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
The effect of central noradrenergic system lesion on dopamine (DA) and serotonin (5-HT) synthesis rate following administration of 5-HT3 receptor ligands in chosen parts of the rat brain.
Topics: Analgesics, Opioid; Animals; Autonomic Nervous System Diseases; Benzylamines; Biguanides; Brain Chem | 2015 |